Dimopoulos, M. A., Siegel, D. S., Lonial, S., Qi, J., Hajek, R., Facon, T., . . . Anderson, K. C. (2013). Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): A multicentre, randomised, double-blind study. The lancet. Oncology, 14(11), . https://doi.org/10.1016/S1470-2045(13)70398-X
Chicago-Zitierstil (17. Ausg.)Dimopoulos, Meletios A., et al. "Vorinostat or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma (VANTAGE 088): A Multicentre, Randomised, Double-blind Study." The Lancet. Oncology 14, no. 11 (2013). https://doi.org/10.1016/S1470-2045(13)70398-X.
MLA-Zitierstil (9. Ausg.)Dimopoulos, Meletios A., et al. "Vorinostat or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma (VANTAGE 088): A Multicentre, Randomised, Double-blind Study." The Lancet. Oncology, vol. 14, no. 11, 2013, https://doi.org/10.1016/S1470-2045(13)70398-X.